These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27462919)

  • 1. Genetic variations in apoptosis pathway and the risk of ovarian cancer.
    Xie H; Tao W; Wu X; Gu J
    Oncotarget; 2016 Aug; 7(35):56737-56745. PubMed ID: 27462919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variations in base excision repair pathway and risk of bladder cancer: a case-control study in the United States.
    Xie H; Gong Y; Dai J; Wu X; Gu J
    Mol Carcinog; 2015 Jan; 54(1):50-7. PubMed ID: 24038406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.
    Liang D; Meyer L; Chang DW; Lin J; Pu X; Ye Y; Gu J; Wu X; Lu K
    Cancer Res; 2010 Dec; 70(23):9765-76. PubMed ID: 21118967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in TGF-β pathway are associated with ovarian cancer risk.
    Yin J; Lu K; Lin J; Wu L; Hildebrandt MA; Chang DW; Meyer L; Wu X; Liang D
    PLoS One; 2011; 6(9):e25559. PubMed ID: 21984931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
    Sun Y; Tao W; Huang M; Wu X; Gu J
    J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
    Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
    Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
    Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
    Xing J; Dinney CP; Shete S; Huang M; Hildebrandt MA; Chen Z; Gu J
    Cancer; 2012 Jan; 118(1):205-15. PubMed ID: 21692063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.
    Michalska MM; Samulak D; Romanowicz H; Jabłoński F; Smolarz B
    Exp Mol Pathol; 2016 Apr; 100(2):243-7. PubMed ID: 26801223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
    Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
    Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
    Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
    Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.
    Ye Y; Wang KK; Gu J; Yang H; Lin J; Ajani JA; Wu X
    Cancer Prev Res (Phila); 2008 Nov; 1(6):460-9. PubMed ID: 19138993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.
    Wang Y; Ye Y; Lin J; Meyer L; Wu X; Lu K; Liang D
    Mol Carcinog; 2015 Jun; 54(6):430-9. PubMed ID: 25867973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk.
    Barry KH; Koutros S; Andreotti G; Sandler DP; Burdette LA; Yeager M; Beane Freeman LE; Lubin JH; Ma X; Zheng T; Alavanja MC; Berndt SI
    Carcinogenesis; 2012 Feb; 33(2):331-7. PubMed ID: 22102698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.
    Pan J; Lin J; Izzo JG; Liu Y; Xing J; Huang M; Ajani JA; Wu X
    Carcinogenesis; 2009 May; 30(5):785-92. PubMed ID: 19270000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer.
    Lu ZH; Gu XJ; Shi KZ; Li X; Chen DD; Chen L
    J Formos Med Assoc; 2016 Jan; 115(1):31-7. PubMed ID: 25659662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.
    Quaye L; Tyrer J; Ramus SJ; Song H; Wozniak E; DiCioccio RA; McGuire V; Høgdall E; Høgdall C; Blaakaer J; Goode EL; Schildkraut JM; Easton DF; Krüger-Kjaer S; Whittemore AS; Gayther SA; Pharoah PD
    PLoS One; 2009 Jun; 4(6):e5983. PubMed ID: 19543528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.
    Pearce CL; Near AM; Van Den Berg DJ; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Anderson AR; Edlund CK; Wu AH; Chen X; Beesley J; Webb PM; Holt SK; Chen C; Doherty JA; Rossing MA; Whittemore AS; McGuire V; DiCioccio RA; Goodman MT; Lurie G; Carney ME; Wilkens LR; Ness RB; Moysich KB; Edwards R; Jennison E; Kjaer SK; Hogdall E; Hogdall CK; Goode EL; Sellers TA; Vierkant RA; Cunningham JM; Schildkraut JM; Berchuck A; Moorman PG; Iversen ES; Cramer DW; Terry KL; Vitonis AF; Titus-Ernstoff L; Song H; Pharoah PD; Spurdle AB; Anton-Culver H; Ziogas A; Brewster W; Galitovskiy V; Chenevix-Trench G; ;
    Br J Cancer; 2009 Jan; 100(2):412-20. PubMed ID: 19127255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The VDR gene FokI polymorphism and ovarian cancer risk.
    Xu H; Li S; Qiu JQ; Gao XL; Zhang P; Yang YX
    Tumour Biol; 2013 Dec; 34(6):3309-16. PubMed ID: 24078452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.